NAD footcare case
This article was originally published in The Tan Sheet
Executive Summary
Profoot Footcare Products' labeling claim that Triad Insoles "relieves knee, leg and back pain" should be discontinued due to lack of supporting scientific evidence, National Advertising Division says in recent NAD Case Reports. Dr. Scholl's marketer Schering-Plough challenged the claim, asserting it is "unqualified and overly broad as it does not distinguish" between different types of pain. Although Profoot explained the Triad design "incorporates a cupped heel for foot stability and an anatomically conforming supportive arch" to alleviate joint pressure, NAD agrees with Schering based on lack of clinical data. Profoot, while disagreeing, said it would amend the claim in future packaging...